{"id":"W1988557714","doi":"10.1016/j.ctrv.2003.10.002","title":"Epidermal growth factor receptor: a promising target in solid tumours","year":2003,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Epidermal growth factor receptor; Monoclonal antibody; Tyrosine kinase; Cancer research; Cancer; Receptor tyrosine kinase; Signal transduction; Targeted therapy; EGFR inhibitors; Cetuximab; Blockade; Pharmacology; Receptor; Immunology; Antibody; Internal medicine; Biology; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008243148,0.001302378,0.002100687,0.002234166,0.0003249283,0.001255317,0.0007927023,0.001455836,0.005071239],"category_scores_gemma":[0.0006433449,0.0003013682,0.0005050566,0.002792013,0.0004452218,0.001646513,0.0005304638,0.001816904,0.003655473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008262415,"about_ca_system_score_gemma":0.001274695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00116896,"about_ca_topic_score_gemma":0.00318953,"domain_scores_codex":[0.99977,0.0000371835,0.00002943096,0.00003576421,0.0001045549,0.00002312716],"domain_scores_gemma":[0.9997097,0.0001285855,0.00004406911,0.000008335453,0.00007521982,0.00003415187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001552033,0.0000891942,0.0001190776,0.01052484,0.00008729262,0.0003670694,0.00003574131,0.0003236285,0.00305092,0.001829484,0.08130823,0.9021094],"study_design_scores_gemma":[0.00005147743,0.0001439147,0.0004415362,0.001554084,0.0001650997,0.001391597,0.00004202003,0.00007168593,0.0005234434,0.0007465497,0.9948556,0.0000129106],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001210416,0.9971686,0.0001786034,0.0004042624,0.0005117049,0.000007423606,0.00002676645,0.0000120509,0.001569624],"genre_scores_gemma":[0.0004926945,0.9971521,0.0002340142,0.0003706818,0.0003045674,0.000008307701,0.0000415741,0.000001884358,0.001394186],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005071239,"threshold_uncertainty_score":0.01696503,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2218575342477881,"score_gpt":0.4851877966864617,"score_spread":0.2633302624386736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}